The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical analysis of optimized neural network risk models to predict clinically significant prostate cancer and avoid unnecessary prostate biopsies.
 
Christopher J.D. Wallis
Honoraria - Bayer; EMD Serono; Haymarket Medical Education; Knight Therapeutics; Tersera; Tolmar
Consulting or Advisory Role - Janssen Oncology; Precision Point Specialty; Sesen Bio
Research Funding - Knight Therapeutics
Travel, Accommodations, Expenses - Tolmar
 
Robert J Paproski
Employment - Nanostics
Leadership - Nanostics
Stock and Other Ownership Interests - Nanostics
Patents, Royalties, Other Intellectual Property - Nanostics
 
Desmond Pink
Employment - Nanostics
Leadership - Nanostics
Stock and Other Ownership Interests - Nanostics
Patents, Royalties, Other Intellectual Property - Nanostics
 
Catalina Vasquez
Employment - Nanostics
Leadership - Nanostics
Stock and Other Ownership Interests - Nanostics
 
Adrian S. Fairey
Employment - Nanostics
Leadership - Nanostics
 
M Eric Hyndman
Employment - Nanostics
 
Armen G. Aprikian
Leadership - Nanostics
 
Adam Kinnaird
No Relationships to Disclose
 
Perrin Beatty
Consulting or Advisory Role - Nanostics
 
Christian P. Pavlovich
Stock and Other Ownership Interests - Amgen; Bristol-Myers Squibb/Celgene; Intuitive Surgical
Honoraria - Profound Medical
Consulting or Advisory Role - Dendreon
Research Funding - Dendreon
 
Leonard S. Marks
No Relationships to Disclose
 
John D Lewis
Employment - Nanostics
Leadership - Nanostics
Stock and Other Ownership Interests - Entos Pharmaceuticals; Nanostics
Patents, Royalties, Other Intellectual Property - Nanostics